Considerable evidence suggests that G-protein-coupled receptors form homomeric and heteromeric dimers in vivo. Unraveling the structural mechanism for cross-talk between receptors in a dimeric complex must start with the identification of the presently unknown dimer interface. Here, by using cysteine cross-linking, we identify the fourth transmembrane segment (TM4) as a symmetrical dimer interface in the dopamine D2 receptor. Cross-linking is unaffected by ligand binding, and ligand binding and receptor activation are unaffected by cross-linking, suggesting that the receptor is a constitutive dimer. The accessibility of adjacent residues in TM4, however, is affected by ligand binding, implying that the interface has functional significance.
INTRODUCTION
G-protein-coupled receptors (GPCRs) comprise a large superfamily of receptors that couple binding of a diverse group of ligands to activation of heterotrimeric G-proteins (1) . A number of class C GPCRs have been shown to form dimers in the plasma membrane, including the calcium-sensing receptor (2) , the GABA B receptor (3) (4) (5) , and the metabotropic glutamate receptors (6) . In the case of the GABA B receptor, heterodimerization is essential for proper trafficking to the cell surface (7) . Furthermore, the evidence supports a scenario in which the binding of GABA to the R1 subunit causes the R2 subunit to bind to and activate G-protein (8, 9) .
In addition, mounting evidence supports the hypothesis that many class A rhodopsin-like receptors, including the dopamine D2 receptor (D2R) (10) (11) (12) (13) , in membrane and in some cases in detergent, are dimeric as well (reviewed in (14) (15) (16) ).
Unraveling the structural mechanism for cross-talk between receptors in a dimeric complex must start with the identification of the presently unknown dimer interface. Two hypotheses have been proposed for GPCR dimerization: domain-swapping and contact dimerization (17, 18) , although recent experimental results seem inconsistent with domain-swapping being the dominant form of dimerization (19, 20) .
Synthetic peptides of TM6 block dimerization and activation of the β2 adrenergic receptor (21) , and it has been suggested that the GXXXG motif in TM6 may be involved in dimerization of this receptor, although this motif is not highly conserved in other family A GPCRs. Synthetic peptides of TM6 and of TM7 also blocked dimerization of the D2 receptor (D2R) (12) . Although these findings were specific to these particular synthetic peptides, the data do not necessarily establish TM6 and/or TM7 as the dimer interface, as the peptide-receptor interactions might modulate the ability of the receptor to form dimers at a different interface. In addition, if the receptors form higher-order oligomers, multiple interfaces must exist.
Computational studies have proposed a number of different potential interfaces (22- Immuno-blotting -Samples were applied to 1.5-mm, 10-well 7.5% acrylamide gels prepared and run according to Laemmli (36) . The bands were transferred to a PVDF membrane (Millipore), which was blocked for 1 hour at room temperature in 5% nonfat milk, 1 % BSA, 0.1% 
RESULTS AND DISCUSSION
Our strategy to identify residues forming the dimer interface in the D2R was to use cysteine cross-linking. Thus, it was essential to develop a system that would allow non-cross-linked receptor to run as a monomer on non-reducing SDS-PAGE. In preliminary experiments using transient transfection of D2R, we found, consistent with previous reports (12) , that a substantial amount of receptor migrated as dimer or higher-order oligomer (data not shown S) ran almost exclusively as a heterogeneously glycosylated monomer of ~65 kDa on non-reducing SDS-PAGE (Fig. 1A) . (As shown below, this background construct, subsequently referred to as D2R, was fully functional and bound multiple ligands normally.) Thus, if the D2R is oligomeric, the oligomer dissociates in SDS. In addition, the D2R is not an obligatory disulfide-linked dimer in the plasma membrane, unlike some class C receptors (2,6).
Using cells stably coexpressing two D2R constructs, one FLAG-tagged and the other Myctagged, we attempted to co-immunoprecipitate Myc-D2R with an anti-FLAG monoclonal antibody and protein G. After solubilization with dodecyl maltoside (DM) we detected no or only trace co-immunoprecipitation of Myc-D2R under these conditions (Fig. 1C) , although the FLAG-D2R was immunoprecipitated as expected (data not shown). Thus, if the D2R is oligomeric in the membrane, the oligomer does not survive DM solubilization.
As a control before introducing engineered cysteines into FLAG-D2R for disulfide crosslinking experiments we reacted FLAG-D2R in intact cells with copper phenanthroline (CuP), an oxidizing reagent that promotes the formation of disulfide bonds directly between cysteines (25, 26) . Reaction with CuP produced a new band of ~133 kDa (Fig. 1A) , approximately twice 9 that of monomer. The fraction of total density that was present in the ~133 kDa band was plotted against increasing CuP (Fig. 1A,B) , giving half-maximal cross-linking at 60 ± 10 µM CuP and maximal cross-linking of 80 ± 14% (n=3).
The cross-linked species size was consistent with it being a homodimer of D2R, but it was possible that it might represent D2R cross-linked to another protein of similar size. The partners in the cross-linked species were definitively identified by co-immunoprecipitation of Myc-D2R stably co-expressed with FLAG-D2R. After reaction with CuP, immunoprecipitation with anti-FLAG antibody produced an ~133 kDa band that was recognized by anti-Myc antibody (Fig.   1C ). In contrast when FLAG-D2R and Myc-D2R were expressed separately and then crosslinked, precipitation with anti-FLAG antibody did not produce a ~133 kDa species recognized by anti-Myc antibody (Fig. 1C) , demonstrating the specificity of the antibodies. These results establish that the ~133 kDa band is a D2R homodimer that is disulfide cross-linked via one of the remaining endogenous cysteines. prevented CuP-induced cross-linking ( Fig. 2A) , demonstrating that this Cys at the extracellular end of TM4 forms the disulfide cross-link at a symmetrical homodimer interface.
To assess ligand binding effects on the receptor's dimerization state we treated cells expressing the background construct with the agonists, quinpirole or bromocriptine, or the antagonists, sulpiride or butaclamol. Neither acute nor 24 hour treatment with these ligands significantly impacted cross-linking under conditions in which nearly all the receptor was crosslinked ( Fig. 2B ). This suggests that the receptor is a constitutive dimer (or possibly a higherorder oligomer) in the plasma membrane and that ligand interaction does not lead to dissociation of the dimer.
To study the effects of cross-linking Cys168 4.58 on ligand binding, we oxidized with 1 mM/4mM CuP to insure that essentially all D2R was cross-linked (see Fig. 1 ). We observed no (Fig. 3C) , or in the K I for sulpiride or dopamine (Fig. 3A,B) . We also assessed the effects of cross-linking Cys168 4.58 on dopamine-mediated inhibition of adenylyl cyclase by the D2R. In the absence of D2R, treatment with 1 mM/4 mM CuP significantly inhibited forskolin-stimulated adenylyl cyclase through a direct effect on adenylyl cyclase (data not shown). This resulted in an apparent decrease in dopamine's potency and efficacy in both the C168 4.58 and C168 4.58 S constructs after treatment with CuP (Fig. 3D) . Nonetheless, after treatment with CuP, dopamine was equally efficacious at inhibiting cyclase in a C168 4.58 construct that was highly cross-linked and in a C168 4.58 S construct that did not cross-link. We observed no dopamine-mediated inhibition of cAMP levels in untransfected EM4 cells. This argues that the dopamine-mediated inhibition of cyclase occurred only via the stably expressed D2R.
Because cross-linking requires that only one of the two cysteines involved is modified initially by the reagent, and the derivatized cysteine then reacts by collision with the second unmodified cysteine, the rate of collision must be much faster than the rate of initial modification. This is consistent with the cysteines being very close initially. The very high fraction of receptor that can be cross-linked, the apparent specificity of the cross-linking, based on the appearance of a single homodimer band, and the lack of cross-linking of Cys56 1.54 , which based on the bovine rhodopsin structure has a similar lipid accessibility as Cys168 4.58 , all argue for the proximity of the TM4 cysteines in the native state. Thus, it is likely that in the membrane, untreated with CuP, D2R exists as a homodimer but that this dimer does not survive detergent solubilization.
Cross-linking does not impair dopamine's ability to inhibit cyclase via the D2R (Fig. 3) , demonstrating that the receptor can bind dopamine and activate G i with a disulfide between antagonists, suggesting that the receptor is a constitutive dimer. These results are consistent with the recent findings of Mercier et al. (27) . Using quantitative bioluminescence resonance energy transfer (BRET), they showed that more than 82% of β2 adrenergic receptor in the plasma membrane exists as a constitutive dimer (or higher-order oligomer) over a broad range of expression levels. They also failed to observe a change in BRET upon addition of ligand, and suggested that the dimer does not form or dissociate upon activation.
Bovine rhodopsin was crystallized in detergent as a non-physiological dimer in which the cytoplasmic face of one molecule is in the same plane as the extracellular face of the second molecule (28). It is possible, however, that the native oligomeric structure of rhodopsin is disrupted in detergent and is therefore not seen in the crystal structure. Indeed, our findings that the dopamine receptor is a dimer in the plasma membrane but cannot be immunoprecipitated from a DM extract argues that the D2-receptor native quaternary structure is not preserved in this detergent. Interestingly, squid rhodopsin in detergent forms 2D crystals that show a TM4 dimer interface (29) (Fig. 4A) . These results suggest that the TM4 dimer interface may be common to other GPCRs as well as the D2R.
Using the substituted-cysteine accessibility method (SCAM) in the D2R, we found that cysteines in TM4 substituted for the highly conserved Trp160 4.50 as well as for Phe164 4.54 and Leu 171 4.61 were accessible to charged sulfhydryl reagents and that this reaction was protected by the antagonist sulpiride (30). We originally inferred that these residues in TM4 faced the binding-site crevice. Surprisingly, in the bovine rhodopsin structure, the aligned residues Our observations regarding the anomalous conservation and accessibility of this "back face" of TM4 suggested to us the possibility that this surface might be at the interface between two D2R subunits (31). Our finding that the site of cross-linking in D2R is Cys168 4.58 at the extracellular end of TM4 directly adjacent to these accessible residues (Fig. 4B) 
